The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients

NCT02366377 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SHR3824
DRUG: Placebo
DRUG: Metformin

Sponsor

Jiangsu HengRui Medicine Co., Ltd.